throbber
Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 1 of 4 PageID #: 1255
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 1 of 4 PageID #: 1255
`
`
`
`
`
`EXHIBIT 43
`
`
`
`
`
`EXHIBIT 43
`
`
`
`
`
`
`

`

`11/6/2020
`
`VeriSeq NIPT Solution v2 FAQs
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 2 of 4 PageID #: 1256
`
`VeriSeq NIPT Solution v2
`Frequently Asked Questions
`
`Support Center / Support Resources:
`
`GENERAL
`
`(cid:0)
`
`What types of samples does the solution use?
`
`The solution uses maternal peripheral whole blood specimens collected in Streck BCT tubes from pregnant women of at least
`10 weeks gestation.
`
`(cid:0)
`
`What equipment do I need to run the VeriSeq NIPT Solution v2?
`
`The solution is performed on three primary pieces of equipment:
`
`A VeriSeq NIPT MicroLab STAR from Hamilton.
`A next-generation sequencing instrument, such as a NextSeq 550Dx.
`A VeriSeq Onsite Server v2 or an existing VeriSeq Onsite Server upgraded to version 2.
`Additional lab equipment is necessary to complete a run. Refer to the VeriSeq NIPT Solution v2 Consumables and Equipment
`list (document # 1000000076886) for a full list of required equipment.
`
`(cid:0)
`
`Does the genomewide screen cover the entire genome?
`
`No. For genomewide screens, certain regions are excluded from analysis. A list of such blacklisted regions is available on the
`Illumina Support product page under Product Files. Genomic anomaly detection is only performed on non-excluded regions.
`
`(cid:0)
`
`Can the solution be performed on women who conceived via assisted reproductive
`technology (ART), including use of a donor egg?
`
`Yes, the solution uses a non-single nucleotide polymorphism (SNP) technology that does not rely on the similarities and
`differences between maternal and fetal cfDNA.
`
`(cid:0)
`
`Can the solution detect polyploidies, such as triploidy?
`
`The solution is not intended to detect polyploidies.
`
`(cid:0)
`
`What is the difference between basic and genomewide screens in the VeriSeq NIPT Solution
`
`https://support.illumina.com/clinical_support/clinical_kits/veriseq-nipt-solution-v2/faqs.html
`
`1/3
`
`

`

`11/6/2020
`
`VeriSeq NIPT Solution v2 FAQs
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 3 of 4 PageID #: 1257
`
`v2?
`
`The basic screen provides information on the trisomy status for chromosomes 21, 18, 13, X, and Y only. Genomewide screens
`provide partial deletions and duplications of 7 MB or more for all autosomes and aneuploidy status for all chromosomes.
`
`In some countries, depending on regulations, fetal sex reporting and sex chromosome aneuploidy (SCA) reporting is not
`available.
`
`LIBRARY PREP
`
`(cid:0)
`
`Can the workflow be prepared manually?
`
`No. The entire workflow is automated.
`
`(cid:0)
`
`How many samples can I run?
`
`You can conduct runs in 24, 48, or 96 sample batches.
`
`(cid:0)
`
`Are index adapters included in the Sample Prep kit?
`
`Yes. The Sample Prep kit includes a DNA Adapter Plate.
`
`(cid:0)
`
`How many sample sequencing libraries can be multiplexed together in one pool?
`
`You can use 24 or 48 sample pools.
`
`(cid:0)
`
`Does the solution require pre- and post-PCR lab spaces?
`
`There is no PCR step in the workflow. Therefore, no post-PCR lab space is required.
`
`SOFTWARE
`
`(cid:0)
`
`Can I run a sample with the basic screen analysis option and then later reanalyze the same
`sample with the genomewide analysis?
`
`No. The sample needs to be reprocessed from the start for another analysis option.
`
`(cid:0)
`
`Can samples on the same run have different screen types?
`
`Yes.
`
`(cid:0)
`
`https://support.illumina.com/clinical_support/clinical_kits/veriseq-nipt-solution-v2/faqs.html
`
`2/3
`
`

`

`11/6/2020
`
`(cid:0)
`
`VeriSeq NIPT Solution v2 FAQs
`Case 1:20-cv-01644-RGA Document 1-43 Filed 12/03/20 Page 4 of 4 PageID #: 1258
`What software does the solution require?
`
`All software is provided with installation.
`
`(cid:0)
`
`Can I download the VeriSeq NIPT Assay Software v2?
`
`No. You must either purchase the VeriSeq Onsite Server v2 with the VeriSeq NIPT Assay Software v2 pre-installed or upgrade
`an existing VeriSeq Onsite Server to v2.
`
`(cid:0)
`
`What chromosomes are reported by the VeriSeq NIPT Assay Software v2?
`
`The basic screen provides information on the trisomy status for chromosomes 21, 18, 13, X, and Y only. Genomewide screens
`provide partial deletions and duplications of 7 MB or more for all autosomes and aneuploidy status for all chromosomes.
`
`In some countries, depending on regulations, fetal sex reporting and sex chromosome aneuploidy reporting (SCA) is not
`available.
`
`(cid:0)
`
`Can I incorporate results with my LIMS system?
`
`Yes, all files are in MD5 format, which makes it easy to incorporate into any LIMS system. However, LIMS software should not
`be installed directly onto the PC for the VeriSeq NIPT MicroLab STAR.
`
`(cid:0)
`
`Does the solution fail samples based on a fetal fraction cutoff?
`
`No.
`
`Contact Us
`
`Other Support
`
`Innovative technologies
`
`At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making
`studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative,
`flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on
`collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this
`challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life
`science research, translational and consumer genomics, and molecular diagnostics.
`For Research Use Only. Not for use in diagnostic procedures (except as specifically noted).
`
`© 2020 Illumina, Inc. All rights reserved.
`
`All trademarks are the property of Illumina, Inc. or their respective owners.
`For specific trademark information, see www.illumina.com/company/legal.html.
`
`Privacy Policy
`
`(cid:0)
`
`(cid:0)
`
`
`
`
`
`
`
`
`
`https://support.illumina.com/clinical_support/clinical_kits/veriseq-nipt-solution-v2/faqs.html
`
`3/3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket